Athebio AG appoints Dr. Jens Hennecke to its Board of Directors Press ReleaseAthebioDecember 15, 2023Athebio AGPress Release
POINT Biopharma and Athebio Announce Partnership to Develop Designed Ankyrin Repeat Protein Targeted Radioligands AthebioSeptember 18, 2023
Shareholders of Athebio AG elect Dr. Hans-Peter Gerber as new member of the Board of Directors Press ReleaseAthebioJuly 20, 2023Athebio AGPress Release
Athebio AG appoints Dr. Hans-Peter Gerber as Scientific Advisor Press ReleaseAthebioMarch 20, 2023Athebio AGPress Release
Athebio AG appoints Dr. Victor Levitsky as Scientific Advisor Press ReleaseAthebioJanuary 6, 2022Athebio AGPress Release